Progress of CDK4/6 inhibitors in the treatment of malignant tumors
CDK4/6 inhibitor acts on cell cycle. It can be used alone or in combination to treat lung cancer, liver cancer, pancreatic cancer and other cancers by restoring normal cell cycle, triggering antitumor immunity and changing the microenvironment of tumors. It has a certain therapeutic effect, and h...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Editorial Board of Journal of Hainan Medical University
2019-11-01
|
Series: | Journal of Hainan Medical University |
Subjects: | |
Online Access: | http://www.hnykdxxb.com/PDF/201911/16.pdf |